Sarah Rundell

Articles written by this Author

999
Sarah Rundell is a staff writer for Top1000funds.com based out of London. She writes on institutional investment across all asset classes, global trade and corporate treasury. She has previously reported on business and investment in Africa and worked as a producer in the BBC’s Business and Economics Unit.
All Authors
Sarah Rundell

Sort content by

Bridgewater and UTIMCO talk China

The $41 billion University of Texas Investment Management has been investing in China since 2007 and its CIO, Britt Harris says it “must be taken seriously”. Presenting at the endowment's board meeting, co-CIO of Bridgewater, Bob Prince, agreed, saying “China is too big to avoid”.

Healthcare’s multiple opportunities

William Haseltine had a long career at Harvard Medical School, educating a generation of doctors, and designing the strategy to develop the first treatment for HIV/AIDS. He addressed the Fiduciary Investors Symposium about important topics in medicine and health development.

Threats to equity bond correlation

A full-blown trade war, and changes in monetary policy triggered by a loss of credibility in the Federal Reserve and other global policy institutions, could result in a return of the positive correlation between bonds and stocks, and investors need to be aware of the risk, warned Luis Viceira, George E. Bates Professor in the Finance Unit and Senior Associate Dean for Executive Education at Harvard Business School, at the Fiduciary Investors’ Symposium at Harvard University.

Inequality risk equal to climate change

Rebecca Henderson, the John and Natty McArthur University Professor at Harvard University who co-teaches Reimagining Capitalism at HBS, says inequality is equal to climate risk in its potential impact. She told delegates at the Fiduciary Investors Symposium at Harvard University when a system no longer generates freedom and prosperity it must be changed. Change is possible because we have the resources and technology to do it. A first move is decent jobs for people at the “bottom”.

We are going to live longer; prepare now

Understanding the economic implications of changing demographics is essential for investors, said Aubrey de Grey, a biomedical gerontologist speaking at the Fiduciary Investors' Symposium at Harvard University He said the technology exists today so that the ageing process can be combated and people will live much longer in the future than what they do today, so really “longevity is a side effect of health”. He urged investors to think about how people living longer will affect consumer behaviour and investee companies.